Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Behestan Pharmaceutical is a prominent Iranian healthcare conglomerate specializing in the importation, marketing, and distribution of advanced pharmaceutical and biological products. Established in 2001, the company serves as a critical bridge between global pharmaceutical innovators and the Iranian healthcare market, representing major international firms such as Novartis, Pfizer, and Abbott. The group operates through specialized subsidiaries, including Behestan Darou for pharmaceutical supply, Behestan Pakhsh for nationwide logistics, and Behestan Tolid for local manufacturing. Their portfolio spans a wide range of therapeutic areas, including oncology, hematology, and neurology, with a focus on high-tech medicines and vaccines. By maintaining rigorous GMP standards and a robust supply chain, Behestan Pharmaceutical ensures the availability of essential life-saving treatments across Iran.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Behestan Pharmaceutical.